Overview
Sigumir is a natural peptide bioregulator extracted from young animal cartilage and bone tissue, containing cartilage-specific peptide fractions.
What problem it targets: It targets degenerative joint wear (osteoarthritis), spinal disc compression, chronic joint stiffness, age-related cartilage thinning, and post-injury joint recovery.
What It Does
• Stimulates chondrocyte repair: Delivers bio-identical natural peptide fragments directly to cartilage cells (chondrocytes), signaling them to rebuild damaged connective tissue.
• Promotes collagen and proteoglycan synthesis: Restores the physical shock-absorbing extracellular matrix of joint cartilage and synovial fluid.
• Rebuilds joint flexibility and reduces stiffness: Improves articular joint mobility and reduces morning stiffness caused by repetitive wear or intense training impact.
• Realistic expectations: Run in 10- to 30-day courses a few times per year. Builds joint cushioning and long-term joint comfort gradually over several weeks to months.
Reconstitution
Finished oral extract: no reconstitution. This profile describes the referenced capsule or sublingual product. A 20 mg dry vial sold under the same name needs its own ingredient identity and supplier preparation instructions.
Presentation
The referenced preparation is a finished tissue-extract supplement. Capsule content and total capsule weight are different; use the exact product label.
Protocol
Community protocols & cycle timing
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Common community cycle pattern | 10–20 consecutive days; a few courses per year with months between courses | Compound- and formulation-specific; see rows below | A shared cycle duration does not establish one shared dose. Oral labels may specify 30-day initial courses or 10-day maintenance courses. |
Product directions
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Referenced capsule product directions | 1–2 times daily with meals; one month | 1–2 capsules per intake | Describes the cited retail formulation, not a clinically established regimen. Verify the current product label; other versions differ. |
About these protocols
The community rows describe reported experience, not a standard or recommended human regimen. Product-label rows apply to the cited formulation; cell and animal rows describe research models. Oral extracts are kept separate from synthetic peptide vials.
Handling & Stacking
- Bioregulators are often discussed as short 10–20-day courses, repeated a few times a year with months between courses, rather than continuous daily use.
- This describes a community cycle pattern, not one universal dose.
- Some finished oral products instead specify a 30-day course or 10-day maintenance course.
- The referenced capsule products are stored dry and protected from light, at +2°C to +25°C.
- Use the expiry date on the actual pack.
- Liquid products may have different storage and opened-container instructions.
- The named preparation is not established here as an approved treatment for its marketed goals.
- Approved alternatives depend on the diagnosed condition and cannot be assigned from an organ label alone.
Safety & Patient Education
- Referenced capsule labels list intolerance to ingredients, pregnancy and lactation as contraindications.
- These are label statements; they do not prove safety in every other situation.
